Balyasny Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,504
| Closed | -$19.6K | – | 2171 |
|
|
2024
Q2 | $19.6K | Buy |
+1,504
| New | +$19.6K | ﹤0.01% | 1835 |
|
|
2023
Q1 | – | Sell |
-817
| Closed | -$41.6K | – | 2437 |
|
|
2022
Q4 | $41.6K | Sell |
817
-38,887
| -98% | -$1.98M | ﹤0.01% | 1930 |
|
|
2022
Q3 | $3.25M | Buy |
39,704
+33,967
| +592% | +$2.78M | 0.01% | 931 |
|
|
2022
Q2 | $388K | Sell |
5,737
-17,095
| -75% | -$1.16M | ﹤0.01% | 1631 |
|
|
2022
Q1 | $2.52M | Buy |
+22,832
| New | +$2.52M | 0.01% | 979 |
|
|
2021
Q4 | – | Sell |
-13,361
| Closed | -$1.17M | – | 2170 |
|
|
2021
Q3 | $1.17M | Buy |
13,361
+10,051
| +304% | +$877K | ﹤0.01% | 1080 |
|
|
2021
Q2 | $512K | Sell |
3,310
-16,102
| -83% | -$2.49M | ﹤0.01% | 1270 |
|
|
2021
Q1 | $3.06M | Sell |
19,412
-4,755
| -20% | -$750K | 0.02% | 729 |
|
|
2020
Q4 | $5.61M | Buy |
+24,167
| New | +$5.61M | 0.03% | 518 |
|
|
2020
Q3 | – | Sell |
-14,870
| Closed | -$4.22M | – | 1221 |
|
|
2020
Q2 | $4.22M | Buy |
+14,870
| New | +$4.22M | 0.04% | 461 |
|
|
2019
Q1 | – | Sell |
-2,764
| Closed | -$389K | – | 1391 |
|
|
2018
Q4 | $389K | Buy |
2,764
+253
| +10% | +$35.6K | ﹤0.01% | 1057 |
|
|
2018
Q3 | $641K | Buy |
+2,511
| New | +$641K | ﹤0.01% | 1090 |
|
|
2016
Q1 | – | Sell |
-960
| Closed | -$191K | – | 1193 |
|
|
2015
Q4 | $191K | Sell |
960
-180
| -16% | -$35.8K | ﹤0.01% | 960 |
|
|
2015
Q3 | $180K | Buy |
+1,140
| New | +$180K | ﹤0.01% | 848 |
|
|
2014
Q4 | – | Sell |
-6,642
| Closed | -$3.48M | – | 551 |
|
|
2014
Q3 | $3.48M | Buy |
+6,642
| New | +$3.48M | 0.03% | 359 |
|